Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05126173 · ClinicalTrials.gov registry record
DERM US and EU Validation Study
A clinical trial of Squamous Cell Carcinoma and Basal Cell Carcinoma, sponsored by Skin Analytics Limited.
- Completed
- Registry status
- 1,111
- Enrollment target
- 16
- Study locations
NCT05126173 is a study of Squamous Cell Carcinoma and Basal Cell Carcinoma that has completed, run by Skin Analytics Limited. The registered enrollment target is 1,111 participants, above the 80-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (1289% higher). The trial reports 16 study locations across 9 states.
The verdict
NCT05126173, a study of Squamous Cell Carcinoma and Basal Cell Carcinoma, has completed, sponsored by Skin Analytics Limited.
- COMPLETED
- Registry status
- 1,111 participants
- Enrollment target
- 16
- Study locations
Study Summary
This study aims establish the effectiveness of Image Analysing Algorithm (DERM) to identify melanoma, Squamous Cell Carcinoma (SCC) and Basal Cell Carcinoma (BCC) when used to analyse dermoscopic images of skin lesions within the US and European population.
Conditions Studied
Interventions
- DEVICE Deep Ensemble for the Recognition of Malignancy (DERM)
Study Locations (16)
Other
- Universitaria Di Bologna - Bologna
- Dermatology University of Florence - Florence
- Università degli Studi di Modena e Reggio Emilia - Modena
- University of Campania - Naples
- Università del Piemonte Orientale - Novara
- UOSD Dermatology Oncology - Roma
Florida
- Vista Health Research, LLC - Miami
- Dorisca Research Consulting, LLC - Miami
Massachusetts
- ALLCUTIS Research, LLC - Beverly
- Allcutis Research - Methuen
California
- Stanford university - Redwood City
Illinois
- Northwestern University - Chicago
New York
- Universal Dermatology, PLLC - Fairport
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Texas
- Alpesh D. Desai, DO, PLLC, a Houston company institution - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,111 participants |
| Start Date | 2022-03-15 |
| Est. Completion | 2022-09-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05126173
The ClinicalTrials.gov registry entry for NCT05126173 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,111 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 80-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (1289% higher). The listed sponsor is Skin Analytics Limited, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Squamous Cell Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Deep Ensemble for the Recognition of Malignancy (DERM) is the first listed.
NCT05126173 reports 16 study locations spanning 9 distinct geographic areas - top geographies include Other, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05126173 about?
NCT05126173 is a clinical study titled "DERM US and EU Validation Study". This study aims establish the effectiveness of Image Analysing Algorithm (DERM) to identify melanoma, Squamous Cell Carcinoma (SCC) and Basal Cell Carcinoma (BCC) when used to analyse dermoscopic images of skin lesions within the US and European population.
What is the current status of trial NCT05126173?
This trial is currently completed. The enrollment target is 1,111 participants. The study started on 2022-03-15. Estimated completion is 2022-09-15.
What conditions does trial NCT05126173 study?
This clinical trial studies the following conditions: Squamous Cell Carcinoma, Basal Cell Carcinoma, Malignant Skin Melanoma T0.
What interventions are being tested in trial NCT05126173?
The interventions under investigation include: Deep Ensemble for the Recognition of Malignancy (DERM) (DEVICE).
Who is sponsoring clinical trial NCT05126173?
This trial is sponsored by Skin Analytics Limited, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05126173 being conducted?
This trial has 16 study locations across California, Florida, Illinois, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Squamous Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
RECRUITING · Phase 2
-
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
RECRUITING · NA
-
Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin
RECRUITING · Phase 2
-
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
RECRUITING · Phase 1
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Toripalimab With Chemotherapy for Sinus Cancer
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.